Jiajing Chen

Featured in: Favicon

tandfonline.com Favicon

dovepress.com Favicon

researcherslinks.com Favicon

diabetesresearchclinicalpractice.com Favicon

onlinelibrary.wiley.com Favicon

pubs.acs.org + 1 more

Articles

Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review

6 days ago | tandfonline.com | Tian Zhang |Yue Stella Yu |Jiajing Chen |Zhao Zhao

AbstractObjective Cryopyrin-associated periodic syndromes (CAPS), a group of interleukin-1 (IL-1) mediated autoinflammatory disorders, were incorporated into China’s “Second List of Rare Diseases” in 2023. Notably, rilonacept, an IL-1 inhibitor approved in the United States since 2008, has been a key treatment for CAPS. However, comprehensive analysis of its efficacy and safety are limited.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →